| 000 | 01363 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516170140.0 | ||
| 264 | 0 | _c20141113 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1534-4681 | ||
| 024 | 7 |
_a10.1245/s10434-013-3254-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHatzaras, Ioannis | |
| 245 | 0 | 0 |
_aTreatment options and surveillance strategies after therapy for hepatocellular carcinoma. _h[electronic resource] |
| 260 |
_bAnnals of surgical oncology _cMar 2014 |
||
| 300 |
_a758-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdiagnosis |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aContinuity of Patient Care |
| 650 | 0 | 4 |
_aDiagnostic Tests, Routine _xstatistics & numerical data |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aSurvivors |
| 700 | 1 | _aBischof, Danielle A | |
| 700 | 1 | _aFahy, Bridget | |
| 700 | 1 | _aCosgrove, David | |
| 700 | 1 | _aPawlik, Timothy M | |
| 773 | 0 |
_tAnnals of surgical oncology _gvol. 21 _gno. 3 _gp. 758-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1245/s10434-013-3254-5 _zAvailable from publisher's website |
| 999 |
_c23060813 _d23060813 |
||